VAR2 PHARMACEUTICALS ApS: Financial statements 2013
CVR: 34621942
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
VAR2 PHARMACEUTICALS ApS (CVR 34621942) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 68,068 and a net result of DKK 65,528. Equity in the 2013 report amounted to DKK 117,514. The solvency ratio was 64.8%.
- Gross Profit
- DKK 68,068
- Profit/Loss
- DKK 65,528
- Equity
- DKK 117,514
- Total Assets
- DKK 181,227
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of November 7, 2013, ONCOMAL ApS is registered as an owner of VAR2 PHARMACEUTICALS ApS with an ownership share of 90%.
VAR2 PHARMACEUTICALS ApS has published its interim report for the period June 1, 2012 – December 31, 2012.
About VAR2 PHARMACEUTICALS ApS
VAR2 PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali El-Salanti and Mads Daugaard. The board consists of Mads Daugaard (chair), Ali El-Salanti, Josef Rainer and Peter Schröcksnadel. The company is owned by ONCOMAL ApS and Københavns Universitet. The company has 10 employees (2026). In 2025, the company reported a gross profit of DKK -21,739,014 and a net result of DKK -19,726,508 compared with DKK -21,006,013 the year before. Equity in the 2025 report amounted to DKK 82,032,248.